Funding brief: The goal of Worldwide Cancer Research is to support research that might in future help reduce the incidence of cancer or improve cancer survival. They award grants to support fundamental or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer. This remit is usually interpreted conservatively.
Donor Name: Worldwide Cancer Research
Funding name: No specific fund name
Deadline: 27th, April, 2018 at 5 PM UK time on Friday (British Local Time)
Funding details link: https://www.worldwidecancerresearch.org/funding-for-research/
Funding limit: The maximum budget allowed is £250,000, but it should be noted that most of the three-year grants they award have a budget below £200,000.
Special Notes: Please contact with the donor directly for further clarification and understanding.
Project start date: If a grant is awarded, it will normally start 9-12 months after the application was submitted.
Project duration: They award project grants from 12 to 36 months in length to principal investigators based at any not-for-profit research institute in the world.
Eligible organization: As below
● Project grants are awarded to a single researcher, known as the Principal Investigator (PI) or Grantholder. The PI is the person with the main responsibility for writing the application, and designing and directing the research project. The PI is also responsible for ensuring all requirements in this handbook and in our grant terms and conditions are complied with.
● The PI must be employed at a recognized, non-profit research institution anywhere in the world. Honorary contracts and emeritus positions are usually acceptable.
● The PI’s research institution must be able to accept the terms and conditions within our grant contract, which can be found in Appendix 1 of this handbook. The grant contract is not negotiable except in the rare situation that a clause conflicts with local or national law. Submitting an application to Worldwide Cancer Research is taken as agreement to the terms of our grant contract therefore PIs must ensure the relevant grant or finance officer at their institution has reviewed the contract in detail before an application is submitted. If an institution is unable to agree to the terms of the grant contract when an offer is made, the offer will be withdrawn and the funding offered to another applicant.
● The PI must have a contract of employment that will last for at least the duration of the grant requested, or be able to show evidence that their current contract would be extended if the grant were awarded.
● A research group can only submit a single application to Worldwide Cancer Research in a grant round. For example, if you are the PI on an application in this round, no member of your research group can be PI on a second application. If, at any stage of a grant round, a research group is found to have submitted multiple applications as PIs, all the applications will be rejected immediately and the group may be barred from applying in future. This rule only applies to PIs. You can be PI on one application and a co-applicant or collaborator on other applications at the same time.
● If the principal investigator on an application is rejected at the preliminary triage review stage of a grant round, they cannot submit an application in the next grant round. Furthermore, the same project cannot be submitted by another principal investigator.
● Other senior researchers who would be substantially involved in managing the project can be included as co-applicants. Co-applicants should be at senior post-doctoral level or above (i.e. with greater than 3-years post-doctoral research experience). Co-applicants do not need to be at the same institution as the PI.
● Where a project is collaborative and involves more than one investigator and/or research institution, one of the applicants must take the role of PI. This must be the investigator whose research group will carry out most of the work on the project.
● If an award is made for a collaborative project it will be made entirely to the PI’s institution. It is the host institution’s responsibility to put in place an arrangement to reimburse costs incurred by other institutions during the project. Worldwide Cancer Research takes no responsibility for ensuring the costs of collaborating laboratories are reimbursed.
● Commercial, for-profit organizations e.g. biotechnology and pharmaceutical companies cannot apply for a grant. Neither is it permitted for a research institution to transfer Worldwide Cancer Research grant funds to a commercial organization except for payment for specific services, items and reagents used in the project. This includes transferring money to spin-out companies from the laboratory or institute.
● Individual scientists from commercial organizations can be named as collaborators if they would provide specific expertise or reagents to the project. The nature of their involvement must be made clear. Scientists from commercial organizations cannot be co-applicants.
● The PI will usually be a PhD-qualified tenured or tenure-track research group leader. Post-doctoral researchers with more than three years post-doctoral research experience at the time of application are also eligible to apply for a grant. Post-doctoral applicants who are not yet independent researchers must name their group head as co-applicant on the grant.
● You cannot apply to Worldwide Cancer Research for a project grant (either as a PI or co-applicant) if you are currently applying for, or have received, funding from the tobacco industry or bodies substantially funded by the tobacco industry, within the last 10 years. See the policy section at the end of this document.
● PIs working in groups or at institutes that receive long-term or core research funding may apply for a grant, but only for a research project that is clearly distinct from that supported by the other funding. Before a grant is awarded we will request documents relating to the other funding to confirm there is no overlap with our award.
● You may apply to other organizations at the same time as Worldwide Cancer Research for funding to support the same project. However, we must be informed of any such ‘parallel’ applications in the relevant section of the application form.
● If you choose to submit parallel applications to fund the same project and are offered a grant by both Worldwide Cancer Research and another organization, you will normally be asked to choose which grant to accept. You are not permitted to double-fund a project or to use your Worldwide Cancer Research grant for a different programme of work to that described in the grant application.
● In rare cases, where a parallel award is much smaller than the Worldwide Cancer Research grant, a PI may be permitted to keep both grants with an appropriate reduction in budget to remove any overlap in funding.
● Worldwide Cancer Research will only accept the first 500 applications submitted in the grant round.
Eligible Country: No country bar found (Open to all regions)
Submission mail: Not found
Other important link:
● Guideline: https://www.worldwidecancerresearch.org/funding-for-research/what-to-consider-before-applying/
● Handbook: https://www.worldwidecancerresearch.org/wp-content/uploads/2018/03/Worldwide-Cancer-Research-Application-Handbook-April-2018.pdf
How to apply: Applicants must register on the Worldwide Cancer Research on-line application system, which can be found at https://www.worldwidecancerresearch.org/funding-for-research/make-an-application/ ● When completing your registration please do not use BLOCK CAPITAL letters for your name, institution and/or country.
● All applications should be completed in English.
Visit all Funding opportunities: https://fundforbangladesh.wordpress.com/site-map/
Visit all funding categories: https://fundforbangladesh.wordpress.com/how-to/access-funding-short-cut/
Facebook page-Fund for Bangladesh